Genetic testing for hereditary breast and ovarian cancer to be subsidised

Genetic testing for hereditary breast and ovarian cancer to be subsidised

Eligible patients can receive up to 70 per cent in subsidies for genetic tests, while MediShield Life coverage will be extended to selected risk-reducing surgical procedures.  

📰 Original Source

Read full article at Channelnewsasia →

KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.